Lipoprotein(a) mass: A massively misunderstood metric
Tài liệu tham khảo
Albers, 2013, Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes), J Am Coll Cardiol, 62, 1575, 10.1016/j.jacc.2013.06.051
Jacobson, 2013, Lipoprotein(a), cardiovascular disease, and contemporary management, Mayo Clin Proc, 88, 1294, 10.1016/j.mayocp.2013.09.003
Lackner, 1993, Molecular definition of the extreme size polymorphism in apolipoprotein(a), Hum Mol Genet, 2, 933, 10.1093/hmg/2.7.933
Utermann, 1989, The mysteries of lipoprotein(a), Science, 246, 904, 10.1126/science.2530631
Albers, 1974, Immunochemical quantification of human plasma Lp(a) lipoprotein, Lipids, 9, 15, 10.1007/BF02533209
Kostner, 1981, Lipoprotein Lp(a) and the risk for myocardial infarction, Atherosclerosis, 38, 51, 10.1016/0021-9150(81)90103-9
Albers, 1990, The unique lipoprotein(a): properties and immunochemical measurement, Clin Chem, 36, 2019, 10.1093/clinchem/36.12.2019
Nakajima, 2001, Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size, Arterioscler Thromb Vasc Biol, 21, 1238, 10.1161/hq0701.092246
Rubin, 2002, Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians, J Lipid Res, 43, 234, 10.1016/S0022-2275(20)30165-6
Baudhuin, 2004, Electrophoretic measurement of lipoprotein(a) cholesterol in plasma with and without ultracentrifugation: comparison with an immunoturbidimetric lipoprotein(a) method, Clin Biochem, 37, 481, 10.1016/j.clinbiochem.2004.02.001
Seman, 1999, Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study, Clin Chem, 45, 1039, 10.1093/clinchem/45.7.1039
Marcovina, 2000, Lipoprotein(a): Structure, Measurement, and Clinical Significance, 345
Guadagno, 2013, Validation of Lp(a) particle number analysis by quantitative Lipo-IFE, J Clin Lipidol, 7, 240, 10.1016/j.jacl.2013.03.020
Seman, 1994, Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction, Clin Chem, 40, 400, 10.1093/clinchem/40.3.400
Brown, 2010, Management of Lp(a), J Clin Lipidol, 4, 240, 10.1016/j.jacl.2010.07.002
Yang, 1986, Determination of the molecular mass of apolipoprotein B-100. A chemical approach, Biochem J, 239, 777, 10.1042/bj2390777
Shen, 1977, Structure of human serum lipoproteins inferred from compositional analysis, Proc Natl Acad Sci U S A, 74, 837, 10.1073/pnas.74.3.837
Marcovina, 1995, Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a), Clin Chem, 41, 246, 10.1093/clinchem/41.2.246
Ellefson, 1971, Pre-beta (or alpha 2) lipoprotein of high density in human blood, Mayo Clin Proc, 46, 328
Jeyarajah, 2006, Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy, Clin Lab Med, 26, 847, 10.1016/j.cll.2006.07.006
Cromwell, 2007, LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management, J Clin Lipidol, 1, 583, 10.1016/j.jacl.2007.10.001
Mora, 2013, High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy, Circulation, 128, 1189, 10.1161/CIRCULATIONAHA.113.002671
Rader, 1994, The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate, J Clin Invest, 93, 2758, 10.1172/JCI117292
Dieplinger, 1999, The seventh myth of lipoprotein(a): where and how is it assembled?, Curr Opin Lipidol, 10, 275, 10.1097/00041433-199906000-00010
Clarke, 2009, Genetic variants associated with Lp(a) lipoprotein level and coronary disease, N Engl J Med, 361, 2518, 10.1056/NEJMoa0902604
Erqou, 2010, Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants, J Am Coll Cardiol, 55, 2160, 10.1016/j.jacc.2009.10.080